Workflow
证券代码:603222 证券简称:济民健康 公告编号:2025-044

Core Viewpoint - The major shareholder, Shuangge Group, plans to reduce its stake in Jimin Health Management Co., Ltd. due to funding needs, which may impact the company's stock performance and investor sentiment [2][3]. Shareholder Holdings - As of the announcement date, Shuangge Group holds 127,983,520 shares in Jimin Health, representing 24.37% of the total share capital [2]. Reduction Plan Details - Shuangge Group intends to reduce its holdings by up to 15,752,718 shares, not exceeding 3% of the total share capital, through centralized bidding and block trading methods [3]. - The reduction will occur within three months after the announcement, starting fifteen trading days later, with a limit of 1% through centralized bidding and 2% through block trading [3]. Shareholder Commitments - The major shareholder and related parties have made commitments regarding share transfer restrictions, including a lock-up period of 36 months from the listing date [5]. - If the stock price falls below the issue price for 20 consecutive trading days within six months post-listing, the lock-up period will automatically extend by six months [6]. Compliance and Regulations - The reduction plan complies with relevant laws and regulations, including the Securities Law of the People's Republic of China and the Shanghai Stock Exchange rules [7].